Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated Mycobacterium tuberculosis

Genomic technologies have the potential to greatly increase the efficiency of the drug development process. As part of our tuberculosis drug discovery program, we used DNA microarray technology to profile drug-induced effects in Mycobacterium tuberculosis. Expression profiles of M. tuberculosis trea...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Betts, Joanna C., McLaren, Alistair, Lennon, Mark G., Kelly, Fiona M., Lukey, Pauline T., Blakemore, Steve J., Duncan, Ken
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2003
Schlagworte:	Mechanisms of Action: Physiological Effects
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC182614/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12936993/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.9.2903-2913.2003
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!